| Sapropterin | hsa03010 | Ribosome | 1.03E-02 | 2 | P46777, P50914 | RPL5, RPL14 | More | |
| Sapropterin | hsa04142 | Lysosome | 3.31E-02 | 3 | P43234, Q9UBR2, P34059 | CTSO, CTSZ, GALNS | More | |
| Sapropterin | hsa04630 | JAK-STAT signaling pathway | 1.44E-02 | 4 | P01106, Q09472, P48551, P16871 | MYC, EP300, IFNAR2, IL7R | More | |
| Sapropterin | hsa04640 | Hematopoietic cell lineage | 1.67E-02 | 4 | P20023, P11836, P09693, P16871 | CR2, MS4A1, CD3G, IL7R | More | |
| Sapropterin | hsa04919 | Thyroid hormone signaling pathway | 4.44E-02 | 3 | P60709, Q09472, P01106 | ACTB, EP300, MYC | More | |
| Sapropterin | hsa05164 | Influenza A | 8.62E-03 | 4 | Q09472, P48551, P29728, P60709 | EP300, IFNAR2, OAS2, ACTB | More | |
| Sapropterin | hsa05169 | Epstein-Barr virus infection | 1.42E-02 | 5 | P20023, P01106, P48551, P29728, P09693 | CR2, MYC, IFNAR2, OAS2, CD3G | More | |
| Sapropterin | hsa05171 | Coronavirus disease - COVID-19 | 1.93E-02 | 4 | P48551, P29728, P46777, P50914 | IFNAR2, OAS2, RPL5, RPL14 | More | |
| Sapropterin | hsa05211 | Renal cell carcinoma | 1.67E-02 | 2 | Q09472, Q99814 | EP300, EPAS1 | More | |
